February 16, 2018
We are very grateful for your continued business and partnership throughout the year of the Rooster. In the year of the Dog we are looking forward to the opportunity to further support you in the in vitro field of Drug-Drug Interactions, Toxicity assessments, Metabolic Stabilities, Metabolite Identifications and Individually-tailored assay designs for investigations with regulatory compliant reports. We are developing continuously new products and services, which we share by our newsletter and science letters. In the next webinar organized by SOLVO, on the 1st of March, Dr. Daniele Zink from the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research, Singapore will give a presentation with the topic “Rapid and accurate high-throughput in vitro prediction of nephrotoxicity in humans with ProxTox-HTS”.
We have complied a summary of take-home messages from the latest FDA draft guidance here. You can also contact us to schedule a discussion with our scientific team and ensure that your designed in vitro transporter studies are fully compliant with the latest regulatory guidance from FDA, EMA and PMDA.
To celebrate with us and take the benefit of a 50% discount on dog Bsep products and services, please contact your local account manager or fill in an inquiry through the website. The offer is valid for any order completed until April 30th, 2018.
Next entry: SOLVO Newsletter: Citoxlab Acquisition